IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 267 filers reported holding IVERIC BIO INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $29,505 | +49.9% | 750 | -7.3% | 0.00% | – |
Q1 2023 | $19,683 | -48.1% | 809 | -54.3% | 0.00% | – |
Q4 2022 | $37,939 | -91.7% | 1,772 | -93.0% | 0.00% | -100.0% |
Q3 2022 | $457,000 | +22750.0% | 25,445 | +15510.4% | 0.00% | – |
Q2 2022 | $2,000 | -88.9% | 163 | -85.1% | 0.00% | – |
Q1 2022 | $18,000 | +5.9% | 1,094 | +7.7% | 0.00% | – |
Q4 2021 | $17,000 | 0.0% | 1,016 | 0.0% | 0.00% | – |
Q3 2021 | $17,000 | +240.0% | 1,016 | +33.5% | 0.00% | – |
Q2 2021 | $5,000 | – | 761 | +1629.5% | 0.00% | – |
Q1 2021 | $0 | – | 44 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |